P. 403

of long-lived  ea control, effective tick control, reduced transmission of some tick-borne infections, and the added bene t of treating or preventing mite infestations. Limiting these infestations improves the lives of animals and of people, protecting the human–animal bond and ensuring that pets remain close members of their human families.
1. Dautel H, Dippel C, Oehme R, et al. Evidence for an increased geographical distribution of Dermacentor reticulatus in Germany and detection of Rickettsia sp. RpA4. Int J Med Microbiol. 2006 May;296 Suppl 40:149-56.
2. Mierzejewska EJ, Estrada-Peña A, Alsarraf M, et al. Mapping of Dermacentor reticulatus expansion in Poland in 2012-2014. Ticks Tick Borne Dis. 2016 Feb;7(1):94-106.
3. Lindgren E, Tälleklint L, Polfeldt T. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus. Environ Health Perspect. 2000 Feb;108(2):119-23.
4. Jaenson TG, Jaenson DG, Eisen L, et al. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012 Jan 10;5:8
5. Smith FD, Ballantyne R, Morgan ER, Wall R. Prevalence, distribution and risk associated with tick infestation of dogs in Great Britain. Med Vet Entomol. 2011 Dec;25(4):377-84
6. Scharlemann JP, Johnson PJ, Smith AA, et al. Trends in Ixodid tick abundance and distribution in Great Britain. Med Vet Entomol. 2008 Sep;22(3):238-47.
7. Ogden NH, Mechai S, Margos G. Changing geographic ranges of ticks and tick-borne pathogens: drivers, mechanisms and consequences for pathogen diversity. Front Cell Infect Microbiol. 2013 Aug 29;3:46.
8. Dahlgren FS, Paddock CD, Springer YP, et al. Expanding range of Amblyomma americanum and simultaneous changes in the epidemiology of spotted fever group rickettsiosis in the United States. Am J Trop Med Hyg. 2016 Jan;94(1):35- 42.
9. Nadolny R, Gaff H, Carlsson J, Gauthier D. Comparative population genetics of two invading ticks: Evidence of the ecological mechanisms underlying tick range expansions. Infect Genet Evol. 2015 Oct;35:153-62.
10. Greay TL, Oskam CL, Gofton AW, et al. A survey of ticks (Acari: Ixodidae) of companion animals in Australia. Parasit Vectors. 2016 May 10;9(1):207.
11. Waudby HP, Petit S. Seasonal density  uctuations of the exotic ornate kangaroo tick, Amblyomma triguttatum triguttatum Koch, and its distribution on Yorke Peninsula, South Australia. Parasitol Res. 2007 Oct;101(5):1203-8.
12. Herndon A, Little SE. Complications of severe tick infestation. Clin Brief. 2015 Apr;4:19-21.
13. Blagburn BL, Dryden MW. Biology, treatment, and control of  ea and tick infestations. Vet Clin North Am Small Anim Pract. 2009 Nov;39(6):1173-200.
14. Thomas JE, Staubus L, Goolsby JL, Reichard MV. Ectoparasites of free- roaming domestic cats in the central United States. Vet Parasitol. 2016 Sep 15;228:17-22.
15. Nagamori Y, Reichard MV. Feline tick-borne diseases. Today Vet Pract. 2015 May;3:69-74.
16. Honsberger NA, Six RH, Heinz TJ, et al. Ef cacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs. Vet Parasitol. 2016 May 30;222:67-72.
17. Beugnet F, Halos L, Larsen D, et al. The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs. Parasit Vectors. 2014 Jun 23;7:283.
18. Taenzler J, Liebenberg J, Roepke RK, Heckeroth AR. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with  uralaner chewable tablets (BravectoTM). Parasit Vectors. 2015 Jun 4;8:305.
19. Jongejan F, Crafford D, Erasmus H, et al. Comparative ef cacy of oral administrated afoxolaner (NexGardTM) and  uralaner (BravectoTM) with topically applied permethrin/imidacloprid (Advantix®) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs. Parasit Vectors. 2016 Jun 17;9(1):348.
20. Beugnet F, de Vos C, Liebenberg J, et al. Ef cacy of afoxolaner in a clinical  eld study in dogs naturally infested with Sarcoptes scabiei. Parasite. 2016;23:26.
21. Fourie JJ, Liebenberg JE, Horak IG, et al. Ef cacy of orally administered  uralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Parasit Vectors. 2015 Mar 28;8:187.
22. Six RH, Becskei C, Mazaleski MM, et al. Ef cacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis. Vet Parasitol. 2016 May 30;222:62-6.
23. Arias PT, Cordero AM. Effectiveness of  uralaner in treating generalized demodicosis in four dogs. Vet Dermatol. 2016 May;27:112.
24. Carithers D, Crawford J, de Vos C, et al. Assessment of afoxolaner ef cacy against Otodectes cynotis infestations of dogs. Parasit Vectors. 2016 Dec 9;9(1):635.
25. Taenzler J, de Vos C, Roepke RK, et al. Ef cacy of  uralaner against Otodectes cynotis infestations in dogs and cats. Parasit Vectors. 2017 Jan 16;10(1):30.
26. Becskei C, De Bock F, Illambas J, et al. Ef cacy and safety of a novel oral isoxazoline, sarolaner (SimparicaTM), for the treatment of sarcoptic mange in dogs. Vet Parasitol. 2016 May 30;222:56-61.
27. Taenzler J, Liebenberg J, Roepke RK, et al. Ef cacy of  uralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Parasit Vectors. 2016 Jul 7;9(1):392.
28. Romero C, Heredia R, Pineda J, et al. Ef cacy of  uralaner in 17 dogs with sarcoptic mange. Vet Dermatol. 2016 Oct;27(5):353-e88.
29. Beugnet F, Halos L, Larsen D, de Vos C. Ef cacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite. 2016;23:14.
An Urban Experience

   401   402   403   404   405